25 XP   0   0   10

Nuwellis Inc
Buy, Hold or Sell?

Let's analyse Nuwellis together

PenkeI guess you are interested in Nuwellis Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nuwellis Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nuwellis Inc

I send you an email if I find something interesting about Nuwellis Inc.

Quick analysis of Nuwellis (30 sec.)










What can you expect buying and holding a share of Nuwellis? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.44
Expected worth in 1 year
$-0.94
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-1.38
Return On Investment
-535.9%

For what price can you sell your share?

Current Price per Share
$0.26
Expected price per share
$0 - $0.4005
How sure are you?
50%

1. Valuation of Nuwellis (5 min.)




Live pricePrice per Share (EOD)

$0.26

Intrinsic Value Per Share

$-13.98 - $-14.12

Total Value Per Share

$-13.54 - $-13.68

2. Growth of Nuwellis (5 min.)




Is Nuwellis growing?

Current yearPrevious yearGrowGrow %
How rich?$2.9m$16.4m-$7.5m-84.9%

How much money is Nuwellis making?

Current yearPrevious yearGrowGrow %
Making money-$5m-$3.6m-$1.4m-28.1%
Net Profit Margin-236.1%-173.6%--

How much money comes from the company's main activities?

3. Financial Health of Nuwellis (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#279 / 339

Most Revenue
#245 / 339

Most Profit
#220 / 339

Most Efficient
#276 / 339

What can you expect buying and holding a share of Nuwellis? (5 min.)

Welcome investor! Nuwellis's management wants to use your money to grow the business. In return you get a share of Nuwellis.

What can you expect buying and holding a share of Nuwellis?

First you should know what it really means to hold a share of Nuwellis. And how you can make/lose money.

Speculation

The Price per Share of Nuwellis is $0.257. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nuwellis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nuwellis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.44. Based on the TTM, the Book Value Change Per Share is $-0.34 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nuwellis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.81-315.2%-0.68-265.6%-0.53-207.7%-0.65-252.2%-0.69-266.8%
Usd Book Value Change Per Share-0.71-277.4%-0.34-134.0%-0.50-194.4%-0.02-8.4%-0.18-69.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.71-277.4%-0.34-134.0%-0.50-194.4%-0.02-8.4%-0.18-69.7%
Usd Price Per Share0.58-2.39-3.21-2.67-2.53-
Price to Earnings Ratio-0.18--0.89--2.62--1.32--1.09-
Price-to-Total Gains Ratio-0.81-3.60--11.89--2.50--1.27-
Price to Book Ratio1.32-1.66-1.68-1.51-1.31-
Price-to-Total Gains Ratio-0.81-3.60--11.89--2.50--1.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.257
Number of shares3891
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.34-0.02
Usd Total Gains Per Share-0.34-0.02
Gains per Quarter (3891 shares)-1,339.68-84.27
Gains per Year (3891 shares)-5,358.72-337.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5359-53690-337-347
20-10717-107280-674-684
30-16076-160870-1011-1021
40-21435-214460-1348-1358
50-26794-268050-1685-1695
60-32152-321640-2022-2032
70-37511-375230-2360-2369
80-42870-428820-2697-2706
90-48228-482410-3034-3043
100-53587-536000-3371-3380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.050.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%16.034.00.032.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.050.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%16.034.00.032.0%

Fundamentals of Nuwellis

About Nuwellis Inc

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Fundamental data was last updated by Penke on 2024-04-11 16:19:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Nuwellis Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nuwellis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nuwellis to the Medical Devices industry mean.
  • A Net Profit Margin of -216.0% means that $-2.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nuwellis Inc:

  • The MRQ is -216.0%. The company is making a huge loss. -2
  • The TTM is -236.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-216.0%TTM-236.1%+20.1%
TTM-236.1%YOY-173.6%-62.5%
TTM-236.1%5Y-242.7%+6.6%
5Y-242.7%10Y-1,145.3%+902.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-216.0%-11.2%-204.8%
TTM-236.1%-19.6%-216.5%
YOY-173.6%-14.4%-159.2%
5Y-242.7%-21.3%-221.4%
10Y-1,145.3%-24.8%-1,120.5%
1.1.2. Return on Assets

Shows how efficient Nuwellis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nuwellis to the Medical Devices industry mean.
  • -56.4% Return on Assets means that Nuwellis generated $-0.56 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nuwellis Inc:

  • The MRQ is -56.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -38.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-56.4%TTM-38.0%-18.4%
TTM-38.0%YOY-16.3%-21.7%
TTM-38.0%5Y-29.8%-8.2%
5Y-29.8%10Y-29.0%-0.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-56.4%-4.0%-52.4%
TTM-38.0%-4.5%-33.5%
YOY-16.3%-4.8%-11.5%
5Y-29.8%-4.0%-25.8%
10Y-29.0%-4.9%-24.1%
1.1.3. Return on Equity

Shows how efficient Nuwellis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nuwellis to the Medical Devices industry mean.
  • -184.2% Return on Equity means Nuwellis generated $-1.84 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nuwellis Inc:

  • The MRQ is -184.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -79.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-184.2%TTM-79.6%-104.6%
TTM-79.6%YOY-22.0%-57.7%
TTM-79.6%5Y-51.7%-27.9%
5Y-51.7%10Y-51.9%+0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-184.2%-3.9%-180.3%
TTM-79.6%-5.6%-74.0%
YOY-22.0%-5.9%-16.1%
5Y-51.7%-6.1%-45.6%
10Y-51.9%-7.0%-44.9%

1.2. Operating Efficiency of Nuwellis Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nuwellis is operating .

  • Measures how much profit Nuwellis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nuwellis to the Medical Devices industry mean.
  • An Operating Margin of -140.8% means the company generated $-1.41  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nuwellis Inc:

  • The MRQ is -140.8%. The company is operating very inefficient. -2
  • The TTM is -208.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-140.8%TTM-208.6%+67.8%
TTM-208.6%YOY-201.8%-6.8%
TTM-208.6%5Y-248.8%+40.2%
5Y-248.8%10Y-1,127.8%+879.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-140.8%-24.1%-116.7%
TTM-208.6%-16.9%-191.7%
YOY-201.8%-13.4%-188.4%
5Y-248.8%-19.2%-229.6%
10Y-1,127.8%-24.0%-1,103.8%
1.2.2. Operating Ratio

Measures how efficient Nuwellis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.41 means that the operating costs are $2.41 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nuwellis Inc:

  • The MRQ is 2.408. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.086. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.408TTM3.086-0.678
TTM3.086YOY3.018+0.068
TTM3.0865Y3.456-0.369
5Y3.45610Y12.212-8.757
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4081.431+0.977
TTM3.0861.426+1.660
YOY3.0181.503+1.515
5Y3.4561.440+2.016
10Y12.2121.371+10.841

1.3. Liquidity of Nuwellis Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nuwellis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.59 means the company has $2.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nuwellis Inc:

  • The MRQ is 2.588. The company is able to pay all its short-term debts. +1
  • The TTM is 3.362. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.588TTM3.362-0.774
TTM3.362YOY5.553-2.191
TTM3.3625Y5.174-1.812
5Y5.17410Y5.669-0.495
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5882.754-0.166
TTM3.3622.763+0.599
YOY5.5533.488+2.065
5Y5.1743.617+1.557
10Y5.6693.514+2.155
1.3.2. Quick Ratio

Measures if Nuwellis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nuwellis to the Medical Devices industry mean.
  • A Quick Ratio of 1.81 means the company can pay off $1.81 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nuwellis Inc:

  • The MRQ is 1.813. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.493. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.813TTM2.493-0.680
TTM2.493YOY4.689-2.196
TTM2.4935Y4.306-1.814
5Y4.30610Y5.021-0.715
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8131.532+0.281
TTM2.4931.656+0.837
YOY4.6892.139+2.550
5Y4.3062.301+2.005
10Y5.0212.255+2.766

1.4. Solvency of Nuwellis Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nuwellis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nuwellis to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.69 means that Nuwellis assets are financed with 69.4% credit (debt) and the remaining percentage (100% - 69.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nuwellis Inc:

  • The MRQ is 0.694. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.389. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.694TTM0.389+0.305
TTM0.389YOY0.276+0.113
TTM0.3895Y0.275+0.114
5Y0.27510Y0.295-0.020
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6940.389+0.305
TTM0.3890.386+0.003
YOY0.2760.338-0.062
5Y0.2750.442-0.167
10Y0.2950.460-0.165
1.4.2. Debt to Equity Ratio

Measures if Nuwellis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nuwellis to the Medical Devices industry mean.
  • A Debt to Equity ratio of 226.8% means that company has $2.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nuwellis Inc:

  • The MRQ is 2.268. The company is just not able to pay all its debts with equity.
  • The TTM is 0.871. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ2.268TTM0.871+1.397
TTM0.871YOY0.440+0.431
TTM0.8715Y0.500+0.370
5Y0.50010Y0.608-0.107
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2680.559+1.709
TTM0.8710.560+0.311
YOY0.4400.478-0.038
5Y0.5000.624-0.124
10Y0.6080.674-0.066

2. Market Valuation of Nuwellis Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nuwellis generates.

  • Above 15 is considered overpriced but always compare Nuwellis to the Medical Devices industry mean.
  • A PE ratio of -0.18 means the investor is paying $-0.18 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nuwellis Inc:

  • The EOD is -0.079. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.179. Based on the earnings, the company is expensive. -2
  • The TTM is -0.888. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.079MRQ-0.179+0.100
MRQ-0.179TTM-0.888+0.708
TTM-0.888YOY-2.617+1.729
TTM-0.8885Y-1.319+0.431
5Y-1.31910Y-1.089-0.230
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.079-0.997+0.918
MRQ-0.179-1.578+1.399
TTM-0.888-2.041+1.153
YOY-2.617-2.761+0.144
5Y-1.319-2.064+0.745
10Y-1.089-1.463+0.374
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nuwellis Inc:

  • The EOD is -0.161. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.363. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.793. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.161MRQ-0.363+0.203
MRQ-0.363TTM-0.793+0.430
TTM-0.793YOY-1.669+0.877
TTM-0.7935Y-1.117+0.325
5Y-1.11710Y-0.999-0.118
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.161-0.935+0.774
MRQ-0.363-1.489+1.126
TTM-0.793-2.994+2.201
YOY-1.669-6.238+4.569
5Y-1.117-4.771+3.654
10Y-0.999-4.736+3.737
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nuwellis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.32 means the investor is paying $1.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nuwellis Inc:

  • The EOD is 0.585. Based on the equity, the company is cheap. +2
  • The MRQ is 1.321. Based on the equity, the company is underpriced. +1
  • The TTM is 1.658. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.585MRQ1.321-0.737
MRQ1.321TTM1.658-0.337
TTM1.658YOY1.676-0.018
TTM1.6585Y1.508+0.150
5Y1.50810Y1.309+0.200
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.5851.890-1.305
MRQ1.3212.379-1.058
TTM1.6582.458-0.800
YOY1.6763.214-1.538
5Y1.5083.833-2.325
10Y1.3094.173-2.864
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Nuwellis Inc.

3.1. Institutions holding Nuwellis Inc

Institutions are holding 3.141% of the shares of Nuwellis Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Renaissance Technologies Corp0.80570.000154800548000
2023-12-31Virtu Financial LLC0.80140.002554507545070
2023-12-31Vanguard Group Inc0.734504995525758106.4512
2023-12-31Goldman Sachs Group Inc0.6379043384433840
2023-12-31Geode Capital Management, LLC0.1649011218-93-0.8222
2023-12-31Tower Research Capital LLC0.019801345-424-23.9683
2023-12-31JPMorgan Chase & Co0.0008057-1-1.7241
2023-12-31Wells Fargo & Co0.00040251178.5714
2023-09-30Royal Bank of Canada0.0002016160
2023-12-31Financial Perspectives Inc0.000201300
2023-12-31Qube Research & Technologies0.00010800
2023-12-31FMR Inc0021100
2023-09-30Susquehanna International Group, LLP000-10404-100
2023-12-31UBS Group AG000-117-100
Total 3.16590.0026215330+167438+77.8%

3.2. Funds holding Nuwellis Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.734504995500
2024-02-29Fidelity Extended Market Index0.156101061900
2024-02-29Fidelity Series Total Market Index0.0088059900
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0021014300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0017011500
2023-12-31SSgA U.S. Extended Market Index Class I0.001308700
2024-03-31State St US Extended Mkt Indx NL Cl C0.001308700
2023-12-31SSgA U.S. Total Market Index Strategy0.0004025-1-3.8462
2023-12-31NT Ext Equity Mkt Idx Fd - L0.000402400
2023-12-31Northern Trust Extended Eq Market Idx0.000402400
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00010500
2023-12-31NT US Market Cap Idx Fd - L0021100
Total 0.907106168500.0%

3.3. Insider Transactions

Insiders are holding 0.062% of the shares of Nuwellis Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-03-15Nestor Jr. JaramilloBUY40984.79

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Nuwellis Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.713-0.344-52%-0.500-30%-0.022-97%-0.179-75%
Book Value Per Share--0.4401.307-66%2.417-82%2.167-80%2.279-81%
Current Ratio--2.5883.362-23%5.553-53%5.174-50%5.669-54%
Debt To Asset Ratio--0.6940.389+78%0.276+151%0.275+152%0.295+136%
Debt To Equity Ratio--2.2680.871+160%0.440+415%0.500+353%0.608+273%
Dividend Per Share----0%-0%-0%-0%
Eps---0.810-0.683-16%-0.534-34%-0.648-20%-0.686-15%
Free Cash Flow Per Share---0.400-0.668+67%-0.561+40%-0.627+57%-0.643+61%
Free Cash Flow To Equity Per Share---0.165-0.533+223%-0.215+30%-0.012-93%-0.110-33%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---14.121--------
Intrinsic Value_10Y_min---13.983--------
Intrinsic Value_1Y_max---2.369--------
Intrinsic Value_1Y_min---2.387--------
Intrinsic Value_3Y_max---6.391--------
Intrinsic Value_3Y_min---6.360--------
Intrinsic Value_5Y_max---9.536--------
Intrinsic Value_5Y_min---9.414--------
Market Cap1747970.080-126%3950956.49616256971.924-76%21863568.952-82%18170251.003-78%17240953.252-77%
Net Profit Margin---2.160-2.361+9%-1.736-20%-2.427+12%-11.453+430%
Operating Margin---1.408-2.086+48%-2.018+43%-2.488+77%-11.278+701%
Operating Ratio--2.4083.086-22%3.018-20%3.456-30%12.212-80%
Pb Ratio0.585-126%1.3211.658-20%1.676-21%1.508-12%1.309+1%
Pe Ratio-0.079+56%-0.179-0.888+395%-2.617+1360%-1.319+636%-1.089+507%
Price Per Share0.257-126%0.5812.390-76%3.215-82%2.672-78%2.535-77%
Price To Free Cash Flow Ratio-0.161+56%-0.363-0.793+118%-1.669+359%-1.117+208%-0.999+175%
Price To Total Gains Ratio-0.360+56%-0.8153.601-123%-11.892+1359%-2.500+207%-1.266+55%
Quick Ratio--1.8132.493-27%4.689-61%4.306-58%5.021-64%
Return On Assets---0.564-0.380-33%-0.163-71%-0.298-47%-0.290-49%
Return On Equity---1.842-0.796-57%-0.220-88%-0.517-72%-0.519-72%
Total Gains Per Share---0.713-0.344-52%-0.500-30%-0.022-97%-0.179-75%
Usd Book Value--2990000.0008891750.000-66%16437500.000-82%14741750.000-80%15498125.000-81%
Usd Book Value Change Per Share---0.713-0.344-52%-0.500-30%-0.022-97%-0.179-75%
Usd Book Value Per Share--0.4401.307-66%2.417-82%2.167-80%2.279-81%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.810-0.683-16%-0.534-34%-0.648-20%-0.686-15%
Usd Free Cash Flow---2718000.000-4546250.000+67%-3817750.000+40%-4264100.000+57%-4370275.000+61%
Usd Free Cash Flow Per Share---0.400-0.668+67%-0.561+40%-0.627+57%-0.643+61%
Usd Free Cash Flow To Equity Per Share---0.165-0.533+223%-0.215+30%-0.012-93%-0.110-33%
Usd Market Cap1747970.080-126%3950956.49616256971.924-76%21863568.952-82%18170251.003-78%17240953.252-77%
Usd Price Per Share0.257-126%0.5812.390-76%3.215-82%2.672-78%2.535-77%
Usd Profit---5509000.000-5052250.000-8%-3631250.000-34%-4413100.000-20%-4665950.000-15%
Usd Revenue--2551000.0002216000.000+15%2135750.000+19%1914000.000+33%1211850.000+111%
Usd Total Gains Per Share---0.713-0.344-52%-0.500-30%-0.022-97%-0.179-75%
 EOD+3 -5MRQTTM+11 -22YOY+11 -225Y+10 -2310Y+9 -24

4.2. Fundamental Score

Let's check the fundamental score of Nuwellis Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.079
Price to Book Ratio (EOD)Between0-10.585
Net Profit Margin (MRQ)Greater than0-2.160
Operating Margin (MRQ)Greater than0-1.408
Quick Ratio (MRQ)Greater than11.813
Current Ratio (MRQ)Greater than12.588
Debt to Asset Ratio (MRQ)Less than10.694
Debt to Equity Ratio (MRQ)Less than12.268
Return on Equity (MRQ)Greater than0.15-1.842
Return on Assets (MRQ)Greater than0.05-0.564
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Nuwellis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.255
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,770
Total Liabilities6,780
Total Stockholder Equity2,990
 As reported
Total Liabilities 6,780
Total Stockholder Equity+ 2,990
Total Assets = 9,770

Assets

Total Assets9,770
Total Current Assets8,209
Long-term Assets1,561
Total Current Assets
Cash And Cash Equivalents 3,800
Net Receivables 1,951
Inventory 1,997
Other Current Assets 461
Total Current Assets  (as reported)8,209
Total Current Assets  (calculated)8,209
+/-0
Long-term Assets
Property Plant Equipment 1,441
Long-term Assets Other 120
Long-term Assets  (as reported)1,561
Long-term Assets  (calculated)1,561
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,172
Long-term Liabilities3,608
Total Stockholder Equity2,990
Total Current Liabilities
Short-term Debt 216
Accounts payable 2,380
Other Current Liabilities 576
Total Current Liabilities  (as reported)3,172
Total Current Liabilities  (calculated)3,172
+/-0
Long-term Liabilities
Capital Lease Obligations 760
Long-term Liabilities  (as reported)3,608
Long-term Liabilities  (calculated)760
+/- 2,848
Total Stockholder Equity
Common Stock1
Retained Earnings -287,626
Other Stockholders Equity 290,425
Total Stockholder Equity (as reported)2,990
Total Stockholder Equity (calculated)2,800
+/- 190
Other
Capital Stock222
Cash and Short Term Investments 3,800
Common Stock Shares Outstanding 3,539
Liabilities and Stockholders Equity 9,770
Net Debt -2,819
Net Invested Capital 2,990
Net Working Capital 5,037
Property Plant and Equipment Gross 4,923
Short Long Term Debt Total 981



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302010-12-312010-06-302009-12-312009-06-302008-12-312008-06-302007-12-312007-06-302006-12-312006-06-302005-12-312005-06-302004-12-312004-06-30
> Total Assets 
1,409
9,803
7,641
6,564
4,750
12,961
7,109
7,781
9,738
4,335
1,983
7,430
4,475
12,721
6,833
10,660
7,430
4,998
2,907
18,606
15,036
11,922
22,643
60,808
55,230
48,876
43,372
37,791
32,373
38,795
34,913
29,367
24,570
17,778
12,997
6,621
7,471
7,822
11,805
9,340
18,455
14,411
10,938
11,791
8,776
15,363
11,428
7,584
5,602
10,047
13,143
23,719
20,012
33,563
29,640
34,095
30,417
26,107
21,998
18,437
24,673
18,479
15,553
11,432
9,770
9,77011,43215,55318,47924,67318,43721,99826,10730,41734,09529,64033,56320,01223,71913,14310,0475,6027,58411,42815,3638,77611,79110,93814,41118,4559,34011,8057,8227,4716,62112,99717,77824,57029,36734,91338,79532,37337,79143,37248,87655,23060,80822,64311,92215,03618,6062,9074,9987,43010,6606,83312,7214,4757,4301,9834,3359,7387,7817,10912,9614,7506,5647,6419,8031,409
   > Total Current Assets 
1,333
9,532
7,001
6,030
4,342
12,674
6,805
7,502
9,496
4,179
1,830
7,284
4,361
12,601
6,699
10,540
6,910
4,477
2,404
18,113
14,557
11,474
22,230
60,377
54,643
48,304
42,800
37,197
31,712
38,007
34,186
28,664
23,652
17,017
12,331
1,328
2,419
2,985
7,169
4,738
17,864
13,817
10,167
11,197
8,127
14,251
10,302
6,051
4,036
8,732
11,729
22,151
18,536
32,138
28,224
32,725
28,126
23,895
19,920
16,440
22,769
16,610
13,748
9,638
8,209
8,2099,63813,74816,61022,76916,44019,92023,89528,12632,72528,22432,13818,53622,15111,7298,7324,0366,05110,30214,2518,12711,19710,16713,81717,8644,7387,1692,9852,4191,32812,33117,01723,65228,66434,18638,00731,71237,19742,80048,30454,64360,37722,23011,47414,55718,1132,4044,4776,91010,5406,69912,6014,3617,2841,8304,1799,4967,5026,80512,6744,3426,0307,0019,5321,333
       Cash And Cash Equivalents 
928
8,691
6,006
4,783
3,363
11,911
6,547
7,186
9,350
4,029
1,625
6,987
3,350
12,244
6,434
10,340
6,560
3,832
1,772
17,446
14,224
10,970
21,526
59,807
54,136
47,421
42,125
36,575
31,293
37,027
33,419
27,899
23,113
16,470
12,049
792
1,323
1,661
5,558
2,513
15,595
10,504
6,995
8,222
5,480
11,489
7,402
3,634
1,279
5,669
7,821
17,947
14,437
27,893
23,978
28,431
24,205
19,300
15,345
12,053
17,737
11,515
8,896
4,930
3,800
3,8004,9308,89611,51517,73712,05315,34519,30024,20528,43123,97827,89314,43717,9477,8215,6691,2793,6347,40211,4895,4808,2226,99510,50415,5952,5135,5581,6611,32379212,04916,47023,11327,89933,41937,02731,29336,57542,12547,42154,13659,80721,52610,97014,22417,4461,7723,8326,56010,3406,43412,2443,3506,9871,6254,0299,3507,1866,54711,9113,3634,7836,0068,691928
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
569
575
0
0
0
000575569000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
24
82
156
196
57
36
130
167
880
212
136
0
0
0
0
0
0
0
0
59
59
59
0
59
59
59
0
0
0
0
0
111
282
406
618
780
545
658
652
787
786
622
932
528
799
727
978
1,048
905
919
1,177
1,069
750
951
1,313
1,100
1,406
1,301
1,176
1,425
1,951
1,9511,4251,1761,3011,4061,1001,3139517501,0691,1779199051,04897872779952893262278678765265854578061840628211100000595959059595900000000136212880167130365719615682240000
       Other Current Assets 
405
841
994
1,248
955
682
102
120
90
115
75
129
131
144
129
200
350
645
632
667
333
504
704
511
448
824
675
563
360
921
767
765
539
547
282
223
137
88
129
108
136
130
205
240
203
350
278
277
161
141
141
235
237
369
413
420
328
350
252
368
396
477
943
947
461
4619479434773963682523503284204133692372351411411612772783502032402051301361081298813722328254753976576792136056367582444851170450433366763264535020012914413112975115901201026829551,248994841405
   > Long-term Assets 
76
270
640
534
408
287
304
279
242
155
153
146
114
120
134
120
520
521
503
493
479
448
413
431
587
572
572
594
661
788
727
703
918
761
666
5,293
5,052
4,837
4,636
4,602
591
594
771
594
649
1,112
1,126
1,533
1,566
1,315
1,414
1,568
1,476
1,425
1,416
1,370
2,291
2,212
2,078
1,997
1,904
1,869
1,805
1,794
1,561
1,5611,7941,8051,8691,9041,9972,0782,2122,2911,3701,4161,4251,4761,5681,4141,3151,5661,5331,1261,1126495947715945914,6024,6364,8375,0525,29366676191870372778866159457257258743141344847949350352152012013412011414615315524227930428740853464027076
       Property Plant Equipment 
74
72
133
142
185
265
304
279
242
155
153
146
114
120
134
120
520
521
503
493
479
448
413
431
587
572
572
594
661
653
598
595
535
462
412
597
540
483
446
575
570
573
576
573
536
1,092
1,105
1,512
1,433
1,294
1,393
1,547
1,455
1,425
1,416
1,370
2,270
2,191
2,057
1,976
1,883
1,763
1,685
1,674
1,441
1,4411,6741,6851,7631,8831,9762,0572,1912,2701,3701,4161,4251,4551,5471,3931,2941,4331,5121,1051,0925365735765735705754464835405974124625355955986536615945725725874314134484794935035215201201341201141461531552422793042651851421337274
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
268
99
189
189
189
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000001891891899926800000000000000000000000000000000000
       Intangible Assets 
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,399
4,392
4,144
3,980
3,817
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000003,8173,9804,1444,3924,39900000000000000000000000000000000012
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
21
21
21
0
0
0
21
21
21
21
21
0
120
0
0
0012002121212121000212121210000000000000000000000000000000000000000000000000
> Total Liabilities 
1,270
8,812
337
393
367
981
219
335
233
888
346
315
458
759
572
1,280
2,840
2,049
2,262
2,271
2,087
2,019
2,250
2,952
3,503
2,667
2,849
2,729
3,158
8,722
10,389
10,932
12,399
10,166
9,308
4,161
5,714
3,970
2,300
2,359
2,217
2,025
2,129
2,138
2,840
2,835
2,994
3,246
3,612
2,343
3,541
3,391
3,694
3,211
3,644
4,114
4,470
4,394
4,334
4,421
12,316
4,815
4,479
3,593
6,780
6,7803,5934,4794,81512,3164,4214,3344,3944,4704,1143,6443,2113,6943,3913,5412,3433,6123,2462,9942,8352,8402,1382,1292,0252,2172,3592,3003,9705,7144,1619,30810,16612,39910,93210,3898,7223,1582,7292,8492,6673,5032,9522,2502,0192,0872,2712,2622,0492,8401,2805727594583153468882333352199813673933378,8121,270
   > Total Current Liabilities 
305
151
337
393
367
981
219
335
233
888
346
315
458
759
572
1,280
2,840
2,049
2,262
2,271
2,087
2,019
2,250
2,952
3,503
2,667
2,849
2,729
3,158
3,679
4,588
6,052
8,058
6,832
6,943
2,798
3,260
3,798
2,164
2,227
2,091
1,899
2,003
2,012
2,840
2,432
2,637
2,937
3,351
2,131
3,335
3,223
3,585
3,163
3,603
3,795
3,307
3,392
3,459
3,611
4,688
4,107
3,825
2,992
3,172
3,1722,9923,8254,1074,6883,6113,4593,3923,3073,7953,6033,1633,5853,2233,3352,1313,3512,9372,6372,4322,8402,0122,0031,8992,0912,2272,1643,7983,2602,7986,9436,8328,0586,0524,5883,6793,1582,7292,8492,6673,5032,9522,2502,0192,0872,2712,2622,0492,8401,280572759458315346888233335219981367393337151305
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
705
1,895
2,867
3,858
3,867
3,938
0
0
0
0
0
0
0
0
0
0
171
176
181
186
191
213
225
230
236
185
135
193
205
213
226
224
222
220
219
216
21621922022222422621320519313518523623022521319118618117617100000000003,9383,8673,8582,8671,89570500000000000000000000000000000
       Accounts payable 
194
0
0
131
220
627
161
270
146
818
278
247
387
668
0
970
1,860
1,647
1,643
1,590
1,156
1,584
1,324
2,042
2,188
2,030
2,092
1,812
2,079
2,233
1,458
2,329
2,832
2,410
2,051
2,169
2,351
2,930
1,520
1,412
862
1,051
838
617
1,133
1,202
1,178
1,427
1,488
787
1,387
929
1,097
1,613
1,787
1,851
1,414
1,797
1,550
1,561
2,245
2,524
2,311
1,707
2,380
2,3801,7072,3112,5242,2451,5611,5501,7971,4141,8511,7871,6131,0979291,3877871,4881,4271,1781,2021,1336178381,0518621,4121,5202,9302,3512,1692,0512,4102,8322,3291,4582,2332,0791,8122,0922,0302,1882,0421,3241,5841,1561,5901,6431,6471,860970066838724727881814627016162722013100194
       Other Current Liabilities 
111
151
337
261
147
354
58
65
87
70
68
69
70
91
572
310
980
402
619
681
931
435
926
910
1,315
637
757
917
1,079
741
1,235
856
1,368
555
954
629
909
868
644
815
1,229
848
1,165
1,395
1,707
228
97
87
85
39
40
57
66
69
54
38
36
1,390
1,696
1,824
2,219
1,361
60
45
576
57645601,3612,2191,8241,6961,39036385469665740398587972281,7071,3951,1658481,2298156448689096299545551,3688561,2357411,0799177576371,3159109264359316816194029803105729170696870876558354147261337151111
   > Long-term Liabilities 
965
8,661
0
131
220
627
161
270
146
818
278
247
387
668
0
970
1,860
1,647
1,643
1,590
1,156
1,584
1,324
2,042
2,188
2,030
2,092
1,812
2,079
5,043
5,801
4,880
4,341
3,334
2,365
1,363
2,454
172
136
132
126
126
126
126
1,133
403
357
309
261
212
206
168
109
48
41
319
1,163
1,002
875
810
7,628
708
654
601
3,608
3,6086016547087,6288108751,0021,16331941481091682062122613093574031,1331261261261261321361722,4541,3632,3653,3344,3414,8805,8015,0432,0791,8122,0922,0302,1882,0421,3241,5841,1561,5901,6431,6471,860970066838724727881814627016162722013108,661965
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
286
179
71
0
0
6,868
0
0
0
0
00006,86800711792860000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
139
991
7,303
6,172
4,384
11,980
6,890
7,446
9,505
3,447
1,637
7,115
4,017
11,961
6,261
9,380
4,600
2,949
645
16,335
12,949
9,903
20,393
57,856
51,727
46,209
40,523
35,062
29,215
30,073
24,524
18,435
12,171
7,612
3,689
2,460
1,757
3,852
9,505
6,981
16,238
12,386
8,809
9,653
5,936
12,528
8,434
4,338
1,990
7,704
9,602
20,328
16,318
30,352
25,996
29,981
25,947
21,713
17,664
14,016
12,357
13,664
11,074
7,839
2,990
2,9907,83911,07413,66412,35714,01617,66421,71325,94729,98125,99630,35216,31820,3289,6027,7041,9904,3388,43412,5285,9369,6538,80912,38616,2386,9819,5053,8521,7572,4603,6897,61212,17118,43524,52430,07329,21535,06240,52346,20951,72757,85620,3939,90312,94916,3356452,9494,6009,3806,26111,9614,0177,1151,6373,4479,5057,4466,89011,9804,3846,1727,303991139
   Common Stock
3,350
14,950
14,630
16,166
17,541
29,266
31,445
37,769
46,205
33,769
38,975
51,704
48,902
0
74,565
600
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
1,843
46
1
6
0
0
0
1
0
0
0
0
0
3
4
0
0
0
0
1
1
1
1
1
6,868
0
0
0
1
10006,8681111100004300000100061461,8432222222222222111111160074,565048,90251,70438,97533,76946,20537,76931,44529,26617,54116,16614,63014,9503,350
   Retained Earnings -287,626-282,117-278,747-273,902-267,417-265,545-261,675-257,389-252,916-248,562-243,290-238,559-233,338-230,252-225,992-222,070-217,502-213,054-208,545-204,115-199,388-195,132-190,891-186,710-182,356-175,219-172,372-169,914-168,974-166,073-162,156-157,968-153,182-146,578-140,020-133,662-126,599-119,856-113,724-107,344-101,012-93,908-87,873-83,653-79,254-75,188-71,892-69,270-65,190-59,950000000000-18,181-13,858-10,584-7,230-5,170-3,129
   Accumulated Other Comprehensive Income 
-53
0
-85
0
-117
0
-25,628
-31,606
-38,225
-31,519
-38,765
-46,151
-46,373
-60,532
-68,304
2,080
2,260
1,186
1,195
1,183
1,185
1,177
1,260
1,095
1,207
1,188
1,185
1,202
1,272
1,282
1,266
1,250
1,246
1,242
1,240
1,234
1,235
1,234
1,229
1,228
1,227
1,228
1,226
1,225
1,223
1,221
1,218
1,219
1,214
1,211
1,209
1,202
-7
-10
-10
-10
-11
-13
-12
-10
38
37
-24
-24
-31
-31-24-243738-10-12-13-11-10-10-10-71,2021,2091,2111,2141,2191,2181,2211,2231,2251,2261,2281,2271,2281,2291,2341,2351,2341,2401,2421,2461,2501,2661,2821,2721,2021,1851,1881,2071,0951,2601,1771,1851,1831,1951,1862,2602,080-68,304-60,532-46,373-46,151-38,765-31,519-38,225-31,606-25,6280-1170-850-53
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
-28
-8,790
-13
589
818
896
1,073
1,283
1,526
1,197
1,427
1,562
1,489
72,493
0
66,650
67,530
71,032
71,341
90,339
91,017
92,378
107,005
150,667
151,530
152,363
153,060
153,714
154,540
162,451
163,276
163,761
164,105
164,336
164,603
167,297
169,496
172,532
180,647
180,972
197,367
197,868
198,474
203,559
204,101
215,422
215,761
216,173
218,278
228,560
234,381
249,378
249,663
268,921
269,296
278,552
278,873
279,114
279,350
279,570
272,868
287,529
289,845
289,980
290,425
290,425289,980289,845287,529272,868279,570279,350279,114278,873278,552269,296268,921249,663249,378234,381228,560218,278216,173215,761215,422204,101203,559198,474197,868197,367180,972180,647172,532169,496167,297164,603164,336164,105163,761163,276162,451154,540153,714153,060152,363151,530150,667107,00592,37891,01790,33971,34171,03267,53066,650072,4931,4891,5621,4271,1971,5261,2831,073896818589-13-8,790-28



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,864
Cost of Revenue-3,881
Gross Profit4,9834,983
 
Operating Income (+$)
Gross Profit4,983
Operating Expense-22,613
Operating Income-17,630-17,630
 
Operating Expense (+$)
Research Development5,422
Selling General Administrative18,246
Selling And Marketing Expenses0
Operating Expense22,61323,668
 
Net Interest Income (+$)
Interest Income0
Interest Expense-3,483
Other Finance Cost-0
Net Interest Income-3,483
 
Pretax Income (+$)
Operating Income-17,630
Net Interest Income-3,483
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-20,201-15,059
EBIT - interestExpense = -21,113
-20,201
-16,726
Interest Expense3,483
Earnings Before Interest and Taxes (EBIT)-17,630-16,718
Earnings Before Interest and Taxes (EBITDA)-17,268
 
After tax Income (+$)
Income Before Tax-20,201
Tax Provision-9
Net Income From Continuing Ops-16,596-20,210
Net Income-20,209
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses26,494
Total Other Income/Expenses Net-2,5713,483
 

Technical Analysis of Nuwellis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nuwellis. The general trend of Nuwellis is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nuwellis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nuwellis Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.3551 < 0.3865 < 0.4005.

The bearish price targets are: .

Tweet this
Nuwellis Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nuwellis Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nuwellis Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nuwellis Inc.

Nuwellis Inc Daily Moving Average Convergence/Divergence (MACD) ChartNuwellis Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nuwellis Inc. The current adx is .

Nuwellis Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nuwellis Inc.

Nuwellis Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nuwellis Inc.

Nuwellis Inc Daily Relative Strength Index (RSI) ChartNuwellis Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nuwellis Inc.

Nuwellis Inc Daily Stochastic Oscillator ChartNuwellis Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nuwellis Inc.

Nuwellis Inc Daily Commodity Channel Index (CCI) ChartNuwellis Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nuwellis Inc.

Nuwellis Inc Daily Chande Momentum Oscillator (CMO) ChartNuwellis Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nuwellis Inc.

Nuwellis Inc Daily Williams %R ChartNuwellis Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nuwellis Inc.

Nuwellis Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nuwellis Inc.

Nuwellis Inc Daily Average True Range (ATR) ChartNuwellis Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nuwellis Inc.

Nuwellis Inc Daily On-Balance Volume (OBV) ChartNuwellis Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nuwellis Inc.

Nuwellis Inc Daily Money Flow Index (MFI) ChartNuwellis Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nuwellis Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Nuwellis Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nuwellis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.255
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nuwellis with someone you think should read this too:
  • Are you bullish or bearish on Nuwellis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nuwellis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nuwellis Inc

I send you an email if I find something interesting about Nuwellis Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Nuwellis Inc.

Receive notifications about Nuwellis Inc in your mailbox!